ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2018

A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma.

Michael J Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.